NCT06992804View on ClinicalTrials.gov

Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

January 20, 2027

Conditions
Alzheimer Disease
Interventions
OTHER

NirsCure with Lecanemab

Near-infrared light therapy (one session per day, 30 minutes per session, 6 sessions per week) combined with lecanemab (10mg/kg).

OTHER

sham NirsCure with Lecanemab

Sham near-infrared light therapy (where only the equipment appearance is consistent with the true near infrared light device, one session per day, 30 minutes per session, 6 sessions per week) in combined with lecanemab (10mg/kg).

OTHER

NirsCure with Lecanemab

Near-infrared light therapy (one session per day, 30 minutes per session, 6 sessions per week) combined with lecanemab (10mg/kg).

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER